Susquehanna International Group
TARO

Susquehanna International Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Susquehanna International Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,300
Closed -$267K – 13508
2024
Q1 		$267K Buy
+6,300
New +$265K ﹤0.01% 9972
2023
Q3 		– Sell
-21,100
Closed -$800K – 13253
2023
Q2 		$800K Buy
+21,100
New +$662K ﹤0.01% 7194
2020
Q3 		– Sell
-7,100
Closed -$472K – 11296
2020
Q2 		$472K Buy
7,100
+1,100
+18% +$73.8K ﹤0.01% 7482
2020
Q1 		$367K Buy
+6,000
New +$445K ﹤0.01% 7587
2019
Q2 		– Sell
-3,100
Closed -$335K – 10975
2019
Q1 		$335K Buy
+3,100
New +$309K ﹤0.01% 7028
2018
Q3 		– Sell
-2,200
Closed -$255K – 10449
2018
Q2 		$255K Buy
+2,200
New +$242K ﹤0.01% 8155
2018
Q1 		– Sell
-20,500
Closed -$2.15M – 10371
2017
Q4 		$2.15M Sell
20,500
-1,100
-5% -$121K ﹤0.01% 3784
2017
Q3 		$2.43M Buy
21,600
+9,300
+76% +$1.01M ﹤0.01% 3555
2017
Q2 		$1.38M Sell
12,300
-600
-5% -$67.8K ﹤0.01% 4608
2017
Q1 		$1.5M Buy
12,900
+5,000
+63% +$553K ﹤0.01% 4271
2016
Q4 		$832K Buy
7,900
+2,800
+55% +$293K ﹤0.01% 5915
2016
Q3 		$564K Buy
5,100
+400
+9% +$53K ﹤0.01% 5857
2016
Q2 		$684K Buy
4,700
+2,200
+88% +$312K ﹤0.01% 5569
2016
Q1 		$358K Sell
2,500
-12,400
-83% -$1.76M ﹤0.01% 6971
2015
Q4 		$2.3M Sell
14,900
-15,500
-51% -$2.26M ﹤0.01% 3753
2015
Q3 		$4.34M Buy
30,400
+14,200
+88% +$1.99M ﹤0.01% 2882
2015
Q2 		$2.33M Buy
16,200
+8,600
+113% +$1.23M ﹤0.01% 4387
2015
Q1 		$1.07M Sell
7,600
-55,500
-88% -$8.54M ﹤0.01% 5627
2014
Q4 		$9.35M Buy
63,100
+55,100
+689% +$8.1M ﹤0.01% 2103
2014
Q3 		$1.23M Buy
8,000
+6,000
+300% +$903K ﹤0.01% 5536
2014
Q2 		$280K Buy
+2,000
New +$222K ﹤0.01% 8499

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Susquehanna International Group's TARO Position: Q1 2024 in Review

Susquehanna International Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 6,668 shares — an estimated $281K sold.

Susquehanna International Group first reported a position in TARO in Q2 2014 and held it in 22 quarters. The position peaked at $5.1M in Q4 2017. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • Susquehanna International Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 6,668 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $281K.
  • Susquehanna International Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 22 quarters.
  • Susquehanna International Group's Taro Pharmaceutical Industries Ltd. position peaked at $5.1M in Q4 2017.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.